Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Dr. John C. ReedExec. VP of Innovative Medicine and R&D | -11.00k | 2.53M | Derivative Exercise and Sale | 229.85 | 24.91k | - |
| 2026-05-01 | Dr. John C. ReedExec. VP of Innovative Medicine and R&D | 14.25k | 0.00 | Derivative Exercise and Retained Stock | - | 24.91k | 133.73% |
| 2026-02-27 | Mr. Robert J. DeckerController & CAO | -4.08k | 538.72k | Derivative Exercise and Sale | 115.67 - 247.87 | 24.46k | - |
| 2026-02-20 | Mr. Timothy SchmidExec. VP & Worldwide Chairman of MedTech | -1.32k | 324.76k | 売り | 245.66 | 26.24k | -4.80% |
| 2026-02-13 | Mr. James SwansonExec. VP & Chief Information Officer | 11.06k | 0.00 | Derivative Exercise and Retained Stock | - | 25.70k | 75.56% |
| 2026-02-13 | Mr. James SwansonExec. VP & Chief Information Officer | -62.08k | 4.91M | Derivative Exercise and Sale | 162.75 - 243.76 | 25.70k | - |
| 2026-02-13 | Mr. James SwansonExec. VP & Chief Information Officer | -4.21k | 1.03M | Sale to Issuer | 243.45 - 244.55 | 25.70k | -14.09% |
| 2026-02-13 | Ms. Vanessa BroadhurstExec. VP of Global Corporate Affairs | 9.49k | 0.00 | Derivative Exercise and Retained Stock | - | 23.00k | 70.28% |
| 2026-02-15 | Ms. Vanessa BroadhurstExec. VP of Global Corporate Affairs | -526.00 | 128.04k | Derivative Exercise and Sale | 243.39 - 243.45 | 23.00k | - |
| 2026-02-17 | Ms. Vanessa BroadhurstExec. VP of Global Corporate Affairs | -5.94k | 1.45M | 売り | 243.39 | 23.00k | -20.53% |
| 2026-02-13 | Ms. Vanessa BroadhurstExec. VP of Global Corporate Affairs | -4.14k | 1.01M | Sale to Issuer | 243.45 - 244.55 | 23.00k | -15.27% |
| 2026-02-13 | Mr. Joaquin DuatoCEO & Chairman | 48.48k | 0.00 | Derivative Exercise and Retained Stock | - | 356.30k | 15.75% |
| 2026-02-13 | Mr. Joaquin DuatoCEO & Chairman | -36.23k | 8.86M | Derivative Exercise and Sale | 243.45 - 244.55 | 356.30k | - |
| 2026-02-13 | Ms. Jennifer L. TaubertExec. VP & Worldwide Chairman of Innovative Medicine | 16.44k | 0.00 | Derivative Exercise and Retained Stock | - | 194.45k | 9.23% |
| 2026-02-13 | Ms. Jennifer L. TaubertExec. VP & Worldwide Chairman of Innovative Medicine | -15.72k | 3.84M | Derivative Exercise and Sale | 243.45 - 244.55 | 194.45k | - |
| 2026-02-13 | Mr. Timothy SchmidExec. VP & Worldwide Chairman of MedTech | 6.93k | 0.00 | Derivative Exercise and Retained Stock | - | 27.56k | 33.60% |
| 2026-02-18 | Mr. Timothy SchmidExec. VP & Worldwide Chairman of MedTech | -22.62k | 2.79M | Derivative Exercise and Sale | 115.67 - 244.53 | 27.56k | - |
| 2026-02-13 | Mr. Timothy SchmidExec. VP & Worldwide Chairman of MedTech | -2.29k | 558.78k | Sale to Issuer | 243.45 - 244.55 | 27.56k | -7.66% |
| 2026-02-13 | Ms. Elizabeth ForminardExec. VP & Chief Legal Officer | 8.02k | 0.00 | Derivative Exercise and Retained Stock | - | 23.57k | 51.58% |
| 2026-02-13 | Ms. Elizabeth ForminardExec. VP & Chief Legal Officer | -8.36k | 2.04M | Derivative Exercise and Sale | 243.45 - 244.55 | 23.57k | - |
| 2026-02-13 | Mr. Robert J. DeckerController & CAO | 2.68k | 0.00 | Derivative Exercise and Retained Stock | - | 24.46k | 12.31% |
| 2026-02-13 | Mr. Robert J. DeckerController & CAO | -1.06k | 257.79k | Derivative Exercise and Sale | 243.45 - 244.55 | 24.46k | - |
| 2026-02-15 | Dr. John C. ReedExec. VP of Innovative Medicine and R&D | -54.84k | 5.22M | Derivative Exercise and Sale | 156.15 - 243.45 | 10.66k | - |
| 2026-02-13 | Ms. Kristen Blair MulhollandExec. VP & Chief HR Officer | 3.42k | 0.00 | Derivative Exercise and Retained Stock | - | 19.83k | 20.85% |
| 2026-02-13 | Ms. Kristen Blair MulhollandExec. VP & Chief HR Officer | -1.59k | 387.15k | Derivative Exercise and Sale | 243.45 - 244.55 | 19.83k | - |
| 2026-02-13 | Mr. Joseph James WolkExec. VP & CFO | -107.78k | 18.01M | Derivative Exercise and Sale | 115.67 - 244.55 | 85.01k | - |
| 2026-02-13 | Ms. Kathryn E. WengelExec. VP and Chief Technical Operations & Risk Officer | 8.33k | 0.00 | Derivative Exercise and Retained Stock | - | 114.66k | 7.84% |
| 2026-02-13 | Ms. Kathryn E. WengelExec. VP and Chief Technical Operations & Risk Officer | -7.27k | 1.78M | Derivative Exercise and Sale | 243.45 - 244.55 | 114.66k | - |
| 2026-02-06 | Mr. Timothy SchmidExec. VP & Worldwide Chairman of MedTech | 5.24k | 533.39k | Derivative Exercise and Retained Stock | 101.87 | 22.92k | 29.62% |
| 2026-02-06 | Mr. Timothy SchmidExec. VP & Worldwide Chairman of MedTech | -10.34k | 1.43M | Derivative Exercise and Sale | 101.87 - 239.99 | 22.92k | - |
| 2026-02-06 | Ms. Kristen Blair MulhollandExec. VP & Chief HR Officer | 2.29k | 233.28k | Derivative Exercise and Retained Stock | 101.87 | 16.41k | 16.22% |
| 2026-02-06 | Ms. Kristen Blair MulhollandExec. VP & Chief HR Officer | -3.34k | 460.63k | Derivative Exercise and Sale | 101.87 - 239.99 | 16.41k | - |
| 2026-02-06 | Ms. Kathryn E. WengelExec. VP and Chief Technical Operations & Risk Officer | 11.68k | 1.19M | Derivative Exercise and Retained Stock | 101.87 | 106.32k | 12.34% |
| 2026-02-06 | Ms. Kathryn E. WengelExec. VP and Chief Technical Operations & Risk Officer | -27.27k | 3.77M | Derivative Exercise and Sale | 101.87 - 239.99 | 106.32k | - |
| 2026-02-05 | Ms. Elizabeth ForminardExec. VP & Chief Legal Officer | 2.70k | 349.03k | Derivative Exercise and Retained Stock | 129.51 | 15.55k | 20.97% |
| 2026-02-05 | Ms. Elizabeth ForminardExec. VP & Chief Legal Officer | -6.23k | 674.84k | Derivative Exercise and Sale | 129.51 - 237.90 | 15.55k | - |
| 2023-08-23 | Dr. Paula A. JohnsonIndependent Director | -11.00 | 0.00 | Sale to Issuer | - | 89.00 | -11.00% |
| 2026-01-26 | Mr. Joaquin DuatoCEO & Chairman | -100.00k | 22.12M | 売り | 220.99 - 221.48 | 307.81k | -24.52% |
| 2025-11-26 | Mr. John G. MorikisDirector | 1.25k | 257.69k | 買い | 206.15 | 1.85k | 208.68% |
| 2025-10-17 | Dr. John C. ReedExec. VP of Innovative Medicine and R&D | -21.72k | 755.61k | Derivative Exercise and Sale | 157.92 - 192.71 | 10.66k | - |
| 2025-09-04 | Ms. Jennifer L. TaubertExec. VP & Worldwide Chairman of Innovative Medicine | -56.47k | 4.29M | Derivative Exercise and Sale | 101.87 - 177.81 | 178.01k | - |
| 2025-08-29 | Ms. Elizabeth ForminardExec. VP & Chief Legal Officer | 1.95k | 225.67k | Derivative Exercise and Retained Stock | 115.67 | 12.85k | 17.90% |
| 2025-08-29 | Ms. Elizabeth ForminardExec. VP & Chief Legal Officer | -9.57k | 588.84k | Derivative Exercise and Sale | 115.67 - 177.20 | 12.85k | - |
| 2025-08-22 | Mr. Joaquin DuatoCEO & Chairman | -125.82k | 9.73M | Derivative Exercise and Sale | 101.87 - 179.21 | 407.79k | - |
| 2025-08-15 | Mr. Joseph James WolkExec. VP & CFO | -16.82k | 1.26M | Derivative Exercise and Sale | 101.87 - 176.91 | 84.98k | - |
| 2025-07-17 | Dr. John C. ReedExec. VP of Innovative Medicine and R&D | -19.14k | 3.13M | 売り | 163.55 | 10.66k | -64.23% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
